Evidence map›Paper›PMID 32580421›Full record

ArticleInternational journal of molecular sciences2020

Analysis of Spatial Distribution and Prognostic Value of Different Pan Cytokeratin Immunostaining Intensities in Breast Tumor Tissue Sections.

Velicko Vranes, Tijana Vujasinović, Nemanja Rajković, Ksenija Kanjer, Nebojša T Milošević, Marko Radulovic

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Velicko VranesDepartment of Basic and Environmental Science, Instituto Tecnológico de Santo Domingo (INTEC), Santo Domingo 10602, Dominican Republic.ORCID 0000-0001-8907-7781
Tijana VujasinovićDepartment of Experimental Oncology, Institute for Oncology and Radiology, 11000 Belgrade, Serbia.
Nemanja RajkovićDepartment of Biophysics, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Ksenija KanjerDepartment of Experimental Oncology, Institute for Oncology and Radiology, 11000 Belgrade, Serbia.
Nebojša T MiloševićDepartment of Biophysics, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Marko RadulovicDepartment of Experimental Oncology, Institute for Oncology and Radiology, 11000 Belgrade, Serbia.ORCID 0000-0002-2314-7457
Oncology Institute of Vojvodina · RSUniversity of Belgrade · RSInstituto Tecnológico de Santo Domingo · DO

Funding

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja 175068
6 · The paper itself

Abstract

Cancer risk prognosis could improve patient survival through early personalized treatment decisions. This is the first systematic analysis of the spatial and prognostic distribution of different pan cytokeratin immunostaining intensities in breast tumors. The prognostic model included 102 breast carcinoma patients, with distant metastasis occurrence as the endpoint. We segmented the full intensity range (0-255) of pan cytokeratin digitized immunostaining into seven discrete narrow grey level ranges: 0-130, 130-160, 160-180, 180-200, 200-220, 220-240, and 240-255. These images were subsequently examined by 33 major (GLCM), fractal and first-order statistics computational analysis features. Interestingly, while moderate intensities were strongly associated with metastasis outcome, high intensities of pan cytokeratin immunostaining provided no prognostic value even after an exhaustive computational analysis. The intense pan cytokeratin immunostaining was also relatively rare, suggesting the low differentiation state of epithelial cells. The observed variability in immunostaining intensities highlighted the intratumoral heterogeneity of the malignant cells and its association with a poor disease outcome. The prognostic importance of the moderate intensity range established by complex computational morphology analyses was supported by simple measurements of its immunostaining area which was associated with favorable disease outcome. This study reveals intratumoral heterogeneity of the pan cytokeratin immunostaining together with the prognostic evaluation and spatial distribution of its discrete intensities.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesFemaleFollow-Up StudiesHumansKeratinsMiddle AgedPrognosisReceptors, EstrogenReceptors, ProgesteroneSpatial AnalysisBiomarkers, TumorERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesKeratinsReceptors, EstrogenReceptors, Progesteronebreast cancerepithelialhistopathologyimage analysisimmunostainingintensity slicingmetastasispan cytokeratinprognosis

Identifiers

PMID32580421
PMCPMC7352516
OpenAlexW3035829157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.